Bessemer Group Inc Elanco Animal Health Inc Transaction History

Bessemer Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$11.49 - $13.65 $40,961 - $48,662	-3,565 Reduced 83.98%	680 $8,000
Q3 2022 Nov 09, 2022	BUY	$12.41 - $32.42 $49,329 - $128,869	3,975 Added 1472.22%	4,245 $53,000
Q2 2022 Aug 10, 2022	SELL	$19.63 - $26.62 $2,218 - $3,008	-113 Reduced 29.5%	270 $6,000
Q4 2021 Jan 27, 2022	SELL	$27.74 - $34.09 $24,272 - $29,828	-875 Reduced 69.55%	383 $11,000
Q3 2021 Nov 12, 2021	BUY	$29.2 - $36.72 $25,024 - $31,469	857 Added 213.72%	1,258 $40,000
Q2 2021 Aug 06, 2021	BUY	$28.76 - $35.98 $517 - $647	18 Added 4.7%	401 $14,000
Q1 2021 May 13, 2021	BUY	$27.85 - $34.49 $10,666 - $13,209	383 New	383 $11,000
Q4 2019 Feb 04, 2020	SELL	$25.29 - $29.45 $9,483 - $11,043	-375 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$25.62 - $34.96 $94.5 Million - $129 Million	-3,686,846 Reduced 99.99%	375 $10,000
Q2 2019 Jul 19, 2019	BUY	$31.11 - $34.79 $115 Million - $128 Million	3,687,221 New	3,687,221 $125 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.